Search

everythinglearnresearchcommunity

for

Search:↓

A patient developed a blister at the injection site after hepatitis C treatment.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Children, especially teenagers, can get severe SARS-CoV infection with symptoms similar to adults, but they typically recover well with supportive care.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Most patients treated with low-dose alpha-interferon for malignant melanoma experienced skin side effects, with hair loss being the most frequent.

Different factors affect where drugs are absorbed in the small intestine, which is important for effective medication use.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

A blood pressure drug, diltiazem, may also help treat influenza.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Skin problems like itching, dry skin, and hair loss are more common in hepatitis C patients after interferon treatment, but lichen planus is not linked to the infection.

Type I interferons play a key role in the development of various skin diseases.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

Some medications might reverse gray hair, especially those that reduce inflammation or stimulate pigment production, and vitamin B might help.

Hepatitis C virus can cause skin diseases and dermatologists play a crucial role in identifying these conditions.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

SSRIs can cause hair loss, especially sertraline, with higher risk in women.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Juniperus plants contain compounds with potential for developing various medical treatments.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

COVID-19 may harm male fertility and damage the reproductive system.